Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/28/16  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Mark Thomas Taylor

Wrong Mark Thomas Taylor?

Managing Director, Phamaceuticals

Phone: (949) ***-**** ext. ****  
Roth Capital Partners , LLC
888 San Clemente Drive
Newport Beach , California 92660
United States

Company Description: ROTH Capital Partners, LLC is a relationship-driven investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity...   more
Background

Employment History

Board Memberships and Affiliations

  • Board Member
    Medical Care Corporation

Education

  • Bachelor of Science degree
    Tulane University
  • D.M.D.
178 Total References
Web References
Mark ...
halluxinc.com [cached]
Mark Taylor
...
Mark Taylor has over 20 years in the specialty pharmaceuticals sector serving as a senior executive of several public companies, and as a sell-side pharmaceutical analyst.
Most recently, Mr. Taylor was Senior Vice President of Corporate Development for Obagi Medical Products Inc., the market share leader in physician-dispensed dermatologics. Valeant Pharmaceuticals International acquired Obagi in April 2013.
Prior to Obagi, Mr. Taylor was Vice President, Diagnostics for MP Biomedicals, LLC, a privately held global provider of infectious disease screening and confirmatory tests.
Mr. Taylor also served Roth Capital Partners for five years where he held the titles of Managing Director of Healthcare Banking and Senior Pharmaceutical Analyst.
Prior to Roth, Mr. Taylor was head of the largest division at ICN Pharmaceuticals Inc. (now Valeant Pharmaceuticals International) as Executive Vice President, North America. Under Mr. Taylor's leadership, ICN expanded its dermatology division by adding prescription products, physician dispensed skin care brands, and light activated devices to its portfolio.
Mr. Taylor also served as Vice President of Business Development at Watson Pharmaceuticals (now Allergan plc.), another large dermatology products provider. During this time Watson made its first foray into dermatology products by acquiring Oclassen Pharmaceuticals, Inc.
Mark is a graduate of Tulane University and serves on the board of Medical Care Corporation, a private company focused on Alzheimer's research and diagnosis.
Mark ...
www.rothchina.com [cached]
Mark Taylor Institutional Sales Professional
mtaylor@roth.com
949-720-7133
ROTH Capital Partners | Institutional Sales Team | Investment Banking
roth.com [cached]
Mark Taylor Institutional Sales Professional
mtaylor@roth.com
949-720-7133
ROTH Capital Partners | Institutional Sales Team | Investment Banking
ww.w.rothcp.com [cached]
Mark Taylor Institutional Sales Professional
mtaylor@roth.com
949-720-7133
ROTH Capital Partners | Institutional Sales Team | Investment Banking
www.roth.com [cached]
Mark Taylor Institutional Sales Professional
mtaylor@roth.com
949-720-7133
Other People with the name "Taylor":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304